Accordion header
濕性老年黃斑病變如果得不到及時治療,有可能在短時間內損害視力,1演變成終身疾病。2
現時已有各種治療方案幫助患者控制病情,醫生會根據個別需要而建議治療方案。2
目前為止,第一線治療是眼內注射抗血管內皮生長因子藥物(又稱為抗VEGF藥物或眼底針),2醫生會利用此類藥物阻止不正常的血管增生,減少出血和滲漏,避免對黃斑結構造成破壞。3
若患者對抗VEGF藥物反應不理想,醫生可能會安排光動力療法,用以控制異常增生。4
提提大家,如對治療有任何疑問,不妨問問你的醫生。
你可能感興趣的內容
參考資料
- Birch DG, Liang FQ. Int J Nanomedicine. 2007;2(1):65-77.
- The Royal College of Ophthalmologists. Age Related Macular Degeneration Services: Recommendations May 2024. Available from: https://www.rcophth.ac.uk/wp-content/uploads/2021/08/AMD-Services-Commissioning-Guidance-Recommendtions.pdf. Accessed 3 Dec 2024.
- Hospital Authority. Intravitreal Anti-Endothelial Growth Factor Injection. Available from: https://www.ekg.org.hk/pilic/public/Ophthal_PILIC/Ophthal_IntravitrealAntiVEGFInjection_0312_eng.pdf. Accessed 13 Nov 2023.
- National Eye Institute. Age-related Macular Degeneration: What You Should Know. Available from: https://www.nei.nih.gov/sites/default/files/2023-02/WhatYouShouldKnow_AMD.pdf. Accessed 13 Nov 2023.
PP-EYL-HK-0435-1 05 Dec 2026